EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Glucocorticoid Hormones as Modulators of the Kynurenine Pathway in Chronic Pain Conditions

Filip Jovanovic, Visnja Jovanovic iD, Nebojsa Nick Knezevic iD

Cells · 18.04.2023 · 12 (8) · 1178

DOI: 10.3390/cells12081178 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 18.04.2023. Verfasst von Filip Jovanovic und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Merit Health Wesley, Hattiesburg, MS 39402, USA. Hauptthemen laut MEDLINE: Kynurenine, Chronic Pain. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The pathogenesis of chronic pain entails a series of complex interactions among the nervous, immune, and endocrine systems. Defined as pain lasting or recurring for more than 3 months, chronic pain is becoming increasingly more prevalent among the US adult population. Pro-inflammatory cytokines from persistent low-grade inflammation not only contribute to the development of chronic pain conditions, but also regulate various aspects of the tryptophan metabolism, especially that of the kynurenine pathway (KP). An elevated level of pro-inflammatory cytokines exerts similar regulatory effects on the hypothalamic–pituitary–adrenal (HPA) axis, an intricate system of neuro–endocrine–immune pathways and a major mechanism of the stress response. As the HPA axis counters inflammation through the secretion of endogenous cortisol, we review the role of cortisol along with that of exogenous glucocorticoids in patients with chronic pain conditions. Considering that different metabolites produced along the KP exhibit neuroprotective, neurotoxic, and pronociceptive properties, we also summarize evidence rendering them as reliable biomarkers in this patient population. While more in vivo studies are needed, we conclude that the interaction between glucocorticoid hormones and the KP poses an attractive venue of diagnostic and therapeutic potential in patients with chronic pain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KynurenineChronic PainHumansGlucocorticoidsHydrocortisoneHypothalamo-Hypophyseal SystemPituitary-Adrenal SystemCytokinesInflammation

Stichwörter der Autor:innen

HPA axischronic paincortisolglucocorticoidsindoleamine 2,3-dioxygenase (IDO)kynurenine pathwaytryptophan 2,3-dioxygenase (TDO)tryptophan metabolism

Substanzen

KynurenineGlucocorticoidsHydrocortisoneCytokines

Autor:innen und Institutionen

  • Department of Internal Medicine, Merit Health Wesley, Hattiesburg, MS 39402, USA.
  • Department of Anesthesiology, Advocate Illinois Masonic Medical Center, Chicago, IL 60657, USA.
  • Department of Anesthesiology, University of Illinois, Chicago, IL 60612, USA.
  • Department of Surgery, University of Illinois, Chicago, IL 60612, USA.

ORCID-Profile: Visnja Jovanovic, Nebojsa Nick Knezevic

Zitieren

APA

Jovanovic, F., Jovanovic, V., & Knezevic, N. N. (2023). Glucocorticoid Hormones as Modulators of the Kynurenine Pathway in Chronic Pain Conditions. Cells, 12(8), 1178. https://doi.org/10.3390/cells12081178

Vancouver

Jovanovic F, Jovanovic V, Knezevic NN. Glucocorticoid Hormones as Modulators of the Kynurenine Pathway in Chronic Pain Conditions. Cells. 2023;12(8):1178. doi:10.3390/cells12081178

BibTeX
@article{Jovanovic2023,
  author = {Jovanovic, Filip and Jovanovic, Visnja and Knezevic, Nebojsa Nick},
  title = {Glucocorticoid Hormones as Modulators of the Kynurenine Pathway in Chronic Pain Conditions},
  journal = {Cells},
  year = {2023},
  volume = {12},
  number = {8},
  pages = {1178},
  doi = {10.3390/cells12081178}
}
Kostenlos starten →